Literature DB >> 7935735

Cryptococcal meningitis with malaria. A case report.

J O Ashiru1, E E Akang.   

Abstract

Cryptococcal meningitis is an uncommon infection globally, including Nigeria. This systemic fungal infection often is associated with immunodeficiency. The most common causes of meningitis in Nigeria in the 2-3 year age group are the malaria parasites and bacteria. The concomitant infections of Cryptococcal neoformans and Plasmodium falciparum are uncommon. We present here the report of a case of fatal cryptococcal meningitis with malaria infection in a 2 year old child from Nigeria (one of the malaria endemic regions of the world). This case emphasizes the importance of doing a combination of fungal and bacterial cultures as well as looking for malarial parasites in the determination of etiological agents of meningitis in any hospital in Africa. We suggest that cerebrospinal fluid from meningitis cases must be cultured using Sabouraud dextrose agar and any growth on the agar must be examined using Indian ink.

Entities:  

Mesh:

Year:  1994        PMID: 7935735     DOI: 10.1007/bf01104006

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  13 in total

1.  Cryptococcal infection following steroid therapy.

Authors:  E GOLDSTEIN; O N RAMBO
Journal:  Ann Intern Med       Date:  1962-01       Impact factor: 25.391

2.  The coincidence of cryptococcosis and disease of the reticulo-endothelial and lymphatic systems.

Authors:  V P COLLINS; A GELLHORN; J R TRIMBLE
Journal:  Cancer       Date:  1951-07       Impact factor: 6.860

3.  Cerebral cryptococcosis in Malaysia.

Authors:  P M Richardson; A Mohandas; N Arumugasamy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

4.  Rapid selective urease test for presumptive identification of Cryptococcus neoformans.

Authors:  B L Zimmer; G D Roberts
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

5.  Cryptococcal antibodies in pigeon breeders' disease.

Authors:  J N Fink; J J Barboriak; L Kaufman
Journal:  J Allergy       Date:  1968-05

6.  Asymptomatic cryptococcal meningitis.

Authors:  H P Liss; D Rimland
Journal:  Am Rev Respir Dis       Date:  1981-07

7.  Cryptococcal meningitis and internal ophthalmoplegia.

Authors:  R L Lesser; R M Simon; H Leon; N Siegel
Journal:  Am J Ophthalmol       Date:  1979-05       Impact factor: 5.258

8.  Cryptococcus neoformans: size range of infectious particles from aerosolized soil.

Authors:  J B Neilson; R A Fromtling; G S Bulmer
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

9.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

10.  Cryptococcal meningitis. A review of 32 years experience.

Authors:  C N De Wytt; P L Dickson; G W Holt
Journal:  J Neurol Sci       Date:  1982-02       Impact factor: 3.181

View more
  3 in total

1.  Concurrent meningitis and vivax malaria.

Authors:  Tuhin Santra; Sumana Datta; Neha Agrawal; Mita Bar; Arnab Kar; Apu Adhikary; Kunal Ranjan
Journal:  J Family Med Prim Care       Date:  2015 Oct-Dec

Review 2.  Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.

Authors:  Isabella Eckerle; Damaris Ebinger; Daniel Gotthardt; Ralf Eberhardt; Philipp A Schnabel; Wolfgang Stremmel; Thomas Junghanss; Christoph Eisenbach
Journal:  Malar J       Date:  2009-07-20       Impact factor: 2.979

3.  Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.

Authors:  Katherine Plewes; Richard J Maude; Aniruddha Ghose; Arjen M Dondorp
Journal:  BMC Infect Dis       Date:  2015-12-03       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.